These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21598345)

  • 1. Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid.
    Ahn SJ; Kim MJ; Hong HS; Kim KA; Song HT
    J Magn Reson Imaging; 2011 Aug; 34(2):310-7. PubMed ID: 21598345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid.
    Kim YK; Kwak HS; Kim CS; Han YM
    J Magn Reson Imaging; 2009 Aug; 30(2):437-43. PubMed ID: 19629973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and characterization of small focal hepatic lesions (≤2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T.
    Song KD; Kim YK; Lee WJ; Lee MW; Park MJ; Hwang J; Lee MH
    Acta Radiol; 2012 Jun; 53(5):485-93. PubMed ID: 22535883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
    Huppertz A; Balzer T; Blakeborough A; Breuer J; Giovagnoni A; Heinz-Peer G; Laniado M; Manfredi RM; Mathieu DG; Mueller D; Reimer P; Robinson PJ; Strotzer M; Taupitz M; Vogl TJ;
    Radiology; 2004 Jan; 230(1):266-75. PubMed ID: 14695400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK; Kim CS; Han YM; Lee YH
    Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods.
    Holzapfel K; Eiber MJ; Fingerle AA; Bruegel M; Rummeny EJ; Gaa J
    Abdom Imaging; 2012 Feb; 37(1):74-82. PubMed ID: 21597893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases.
    Bennett GL; Petersein A; Mayo-Smith WW; Hahn PF; Schima W; Saini S
    AJR Am J Roentgenol; 2000 Feb; 174(2):477-85. PubMed ID: 10658728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
    Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
    J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between hepatic cyst and hemangioma: additive value of breath-hold, multisection fluid-attenuated inversion-recovery magnetic resonance imaging using half-Fourier acquisition single-shot turbo-spin-echo sequence.
    Sasaki K; Ito K; Koike S; Fujita T; Okazaki H; Matsunaga N
    J Magn Reson Imaging; 2005 Jan; 21(1):29-36. PubMed ID: 15611940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
    Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
    J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging.
    McFarland EG; Mayo-Smith WW; Saini S; Hahn PF; Goldberg MA; Lee MJ
    Radiology; 1994 Oct; 193(1):43-7. PubMed ID: 8090920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI.
    Kim YK; Lee YH; Kim CS; Lee MW
    Abdom Imaging; 2011 Aug; 36(4):425-32. PubMed ID: 21748468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
    Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
    Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal liver lesions: characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging.
    Schima W; Saini S; Echeverri JA; Hahn PF; Harisinghani M; Mueller PR
    Radiology; 1997 Feb; 202(2):389-93. PubMed ID: 9015063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic lesions: discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging.
    Ito K; Mitchell DG; Outwater EK; Szklaruk J; Sadek AG
    Radiology; 1997 Sep; 204(3):729-37. PubMed ID: 9280251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.